Stockscreener 앱 받기
4.82
16.59%
0.72
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
HC Wainwright Has Positive Estimate for TSE:BCT Q2 Earnings - MarketBeat
United Therapeutics president sells $3.5m in stock - MSN
BriaCell Stock Climbs After ‘Unprecedented’ Immunotherapy Response In Breast Cancer Patient, Retail Exudes Optimism - MSN
H.C. Wainwright raises Briacell stock target to $32 on trial success - Investing.com
BriaCell announces public offering of common shares - MSN
BriaCell Therapeutics (NASDAQ:BCTX) Given New $32.00 Price Target at HC Wainwright - Defense World
BriaCell announces public offering of common shares By Investing.com - Investing.com South Africa
BriaCell Therapeutics slumps 20%, prices $3M stock offering - MSN
BriaCell Therapeutics Announces $3.05 Million Public Offering - TipRanks
Briacell Therapeutics Prices Public Offering Of 762,500 Shares At $4 Each -February 03, 2025 at 08:04 pm EST - Marketscreener.com
BriaCell's $3.05M Capital Raise: Strategic Move or Dilution Concern? - StockTitan
BriaCell Therapeutics stock rises on positive clinical trial results - MSN
BriaCell Therapeutics Announces Pricing of Public Offering - GlobeNewswire
Wavelo Secures Four-Year Contract Renewal with EchoStar - The Globe and Mail
Briacell Therapeutics Announces Proposed Public Offering Of Common Shares -February 03, 2025 at 05:36 pm EST - Marketscreener.com
BriaCell Therapeutics Shares Hit Record Low After Public Offering News - MarketWatch
BriaCell Therapeutics Announces Public Offering to Fuel Growth - TipRanks
BriaCell Therapeutics Corp (BCTX) Stock: Navigating Drops and Gains - The InvestChronicle
BriaCell Therapeutics Announces Proposed Public Offering of Common Shares - GlobeNewswire
BriaCell Therapeutics Announces Proposed Public Offering of Common Shares - Benzinga
Cancer Immunotherapy Pioneer BriaCell Launches Strategic Funding Round for Next-Gen Treatments - StockTitan
Will BriaCell Therapeutics Corp (BCTX) meet earnings estimates this quarter? - US Post News
BriaCell Stock Climbs After ‘Unprecedented’ Immunotherapy Response In Breast Cancer Patient, Retail Exudes Opt - Asianet Newsable
Promising Results and Strategic Expansion Underpin Buy Rating for BriaCell Therapeutics - TipRanks
BriaCell immunotherapy destroys metastatic breast cancer tumor | 2025-02-03 | Investing News - Stockhouse Publishing
BriaCell’s Bria-OTS™ Shows Promising Results in Resolving Breast Cancer Lung Metastasis - TipRanks
BriaCell announces resolution of lung metastasis in patient receiving Bria-OTS - TipRanks
BriaCell Therapeutics stock rises on positive clinical trial results By Investing.com - Investing.com UK
BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™ - Markets Insider
BriaCell Therapeutics (BCTX) Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS - StreetInsider.com
Breakthrough in Breast Cancer Treatment: Patient's Lung Metastasis Vanishes After Novel Immunotherapy - StockTitan
Sirius XM Earnings: What To Look For From SIRI - The Globe and Mail
1-800-FLOWERS (FLWS) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
BriaCell Therapeutics (OTCMKTS:BCTXF) Shares Down 2.3% – Here’s What Happened - Defense World
BriaCell Announces Completion of 15:1 Share Consolidation - GlobeNewswire
BriaCell Completes 15:1 Share Consolidation for Nasdaq Compliance - TipRanks
BriaCell's Major Stock Transformation: 44M Shares Become 2.9M in Critical Nasdaq Move - StockTitan
BriaCell Therapeutics (NASDAQ:BCTXW) Shares Down 11.4% – Here’s Why - Defense World
5 AI Stocks to Load Up On in 2025 - The Globe and Mail
Why Truist Analysts Think Nvidia Stock Can Gain Another 50% in 2025 - The Globe and Mail
BriaCell Therapeutics (NASDAQ:BCTX) Shares to Reverse Split on Wednesday, January 29th - Defense World
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 10-JAN-2025. - Marketscreener.com
BriaCell Therapeutics (CVE:BCT) Stock Price Down 3.8% – Here’s Why - Defense World
BCTX stock touches 52-week low at $0.46 amid sharp annual decline - Investing.com
BriaCell Therapeutics (OTCMKTS:BCTXF) Shares Up 2.7% – Here’s Why - Defense World
BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025 - The Manila Times
BriaCell Announces Proposed Effective Date of Share Consolidation - The Manila Times
BriaCell Announces 15:1 Share Consolidation to Maintain Nasdaq Listing Compliance - StockTitan
Bullish BriaCell Therapeutics Insider Buying Worth US$5.52m Yet To Pay Off - Simply Wall St
Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m - Yahoo Finance
BCTXBriacell Therapeutics Corp. Common Shares Latest Stock News & Market Updates - StockTitan
BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures - GlobeNewswire
BriaPro Therapeutics Corp. Announces Availability of Annual - GlobeNewswire
BriaPro Therapeutics Announces Digital Voting Process for 2025 Annual Meeting Amid Postal Strike - StockTitan
Vancouver biotech BriaCell to raise US$5.5 million in share offering - Business in Vancouver
0.93%
1.45%
자본화:
|
볼륨(24시간):